Skip to main content
Keri Ann Pfeil on Muck Rack

Keri Ann Pfeil

As seen in: EClinicalMedicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Keri Ann

Contact Keri Ann, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records

|
By Eric Edward Irons, Keri Ann Pfeil, Jaime Perez, Jaime Pérez, Koen van Besien
| EClinicalMedicine Verified
Keywords Glucagon-like peptide 1 receptor agonist Sodium glucose cotransporter 2 inhibitor Obesity Diabetes mellitus Multiple myeloma Evidence before this study Obesity has been associated with an increased risk of certain hematologic cancers. Although the weight loss-inducing GLP-1 receptor agonists are associated with risk reduction for obesity-related cancers, it is unclear whether they also alter the risk of hematologic malignancies.
Open in Who Shared Issue with article?
See all 1 articles